Extend Biosciences Inc. is a clinical stage biotechnology company developing a novel D-VITylation® drug delivery platform technology that improves the pharmacokinetic properties of peptides and proteins. Peptides have been particularly challenging to bring to market because they are removed from circulation prior to administering therapeutic value.